###begin article-title 0
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 81 86 <span type="species:ncbi:9606">Human</span>
Multiple Anaphase-promoting Complex/Cyclosome Degrons Mediate the Degradation of Human Sgo1*
###end article-title 0
###begin p 1
###xml 247 276 247 276 <email xmlns:xlink="http://www.w3.org/1999/xlink">hongtao.yu@utsouthwestern.edu</email>
###xml 255 257 <span type="species:ncbi:37334">yu</span>
 An Investigator at the Howard Hughes Medical Institute. To whom correspondence should be addressed: Dept. of Pharmacology, UT Southwestern Medical Center, 6001 Forest Park Rd, Dallas, TX 75390-9041. Tel.: 214-645-6161; Fax: 214-645-6156; E-mail: hongtao.yu@utsouthwestern.edu. 
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 548 552 548 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 554 562 554 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 484 489 <span type="species:ncbi:9606">human</span>
Shugoshin 1 (Sgo1) protects centromeric sister-chromatid cohesion in early mitosis and, thus, prevents premature sister-chromatid separation. The protein level of Sgo1 is regulated during the cell cycle; it peaks in mitosis and is down-regulated in G1/S. Here we show that Sgo1 is degraded during the exit from mitosis, and its degradation depends on the anaphase-promoting complex/cyclosome (APC/C). Overexpression of Cdh1 reduces the protein levels of ectopically expressed Sgo1 in human cells. Sgo1 is ubiquitinated by APC/C bound to Cdh1 (APC/CCdh1) in vitro. We have further identified two functional degradation motifs in Sgo1; that is, a KEN (Lys-Glu-Asn) box and a destruction box (D box). Although removal of either motif is not sufficient to stabilize Sgo1, Sgo1 with both KEN box and D box deleted is stable in cells. Surprisingly, mitosis progresses normally in the presence of non-degradable Sgo1, indicating that degradation of Sgo1 is not required for sister-chromatid separation or mitotic exit. Finally, we show that the spindle checkpoint kinase Bub1 contributes to the maintenance of Sgo1 steady-state protein levels in an APC/C-independent mechanism.
###end p 4
###begin p 5
###xml 49 78 49 78 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 85 92 85 92 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">GM76481</grant-num>
###xml 130 155 130 155 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">March of Dimes Foundation</grant-sponsor>
###xml 161 177 161 177 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Welch Foundation</grant-sponsor>
###xml 187 216 187 216 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Leukemia and Lymphoma Society</grant-sponsor>
###xml 359 372 359 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported, in whole or in part, by National Institutes of Health Grant GM76481. This work was also supported by the March of Dimes Foundation, the Welch Foundation, and the Leukemia and Lymphoma Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 5
###begin p 6
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 6
###begin p 7
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1072 1073 1072 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 499 504 <span type="species:ncbi:9606">Human</span>
Loss of sister-chromatid cohesion triggers chromosome segregation in mitosis and occurs in two steps in vertebrate cells (1-3). In prophase, cohesin is phosphorylated by mitotic kinases including Plk1 and removed from chromosome arms (1, 4). Then, cleavage of centromeric cohesin by separase takes place at the metaphase-to-anaphase transition to allow sister-chromatid separation (5). The shugoshin (Sgo) family of proteins plays an important role in the protection of centromeric cohesion (6, 7). Human cells depleted of Sgo1 by RNAi undergo massive chromosome missegregation (8-11). In cells with compromised Sgo1 function, centromeric cohesin is improperly phosphorylated and removed (4, 11), resulting in premature sister-chromatid separation. It has been shown recently that Sgo1 collaborates with PP2A to counteract the action of Plk1 and other mitotic kinases and to protect centromeric cohesin from premature removal (12-14). In addition, Sgo1 has also been shown to promote stable kinetochore-microtubule attachment and sense tension across sister kinetochores (8, 15). Thus, Sgo1 is crucial for mitotic progression and chromosome segregation.
###end p 7
###begin p 8
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">2</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 572 574 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XX</italic>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XXX</italic>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 885 889 885 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1440 1442 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
Orderly progression through mitosis is regulated by the anaphase-promoting complex/cyclosome (APC/C),2 a large multiprotein ubiquitin ligase that targets key mitotic regulators for destruction by the proteasome (16). APC/C selects substrates for ubiquitination by using the Cdc20 or Cdh1 activator proteins to recognize specific sequences called APC/C degrons within target proteins (17). Several APC/C degrons have been characterized, including the destruction box (D box) and the Lys-Glu-Asn box (KEN box) (18, 19). The D box, with the consensus amino acid sequence of RXXLXXXN(X indicates any amino acid), are found in many APC/C substrates, including mitotic cyclins and are essential for their ubiquitin-mediated destruction. The KEN box, which contains a consensus KEN motif, is also found in several APC/C substrates and is preferentially but not exclusively recognized by APC/CCdh1. When APC/C is active, it directs progression through and exit from mitosis by catalyzing the ubiquitination and timely destruction of mitotic regulators, including cyclin A, cyclin B, and the separase inhibitor securin (16). The APC/C activity needs to be tightly controlled to prevent unscheduled substrate degradation. An important mechanism for APC/C regulation is the spindle checkpoint, which prevents the activation of APC/C and destruction of its substrates in response to kinetochores that have not properly attached to the mitotic spindle (20).
###end p 8
###begin p 9
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 273 277 273 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 355 362 355 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 382 390 382 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 432 439 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 490 495 <span type="species:ncbi:9606">human</span>
Recent evidence shows that Sgo1 is a substrate of APC/C, and its protein levels oscillate during the cell cycle (8, 9). In this article we study the degradation of Sgo1 in human cells. We show that Sgo1 is degraded during mitotic exit, and this degradation depends on APC/CCdh1. We further show that both KEN and D boxes are required for Sgo1 degradation in vivo and ubiquitination in vitro. Removal of these motifs stabilizes Sgo1 in vivo. The prolonged presence of stable Sgo1 protein in human cells does not change the kinetics of chromosome segregation and mitotic exit. Therefore, a timely scheduled degradation of Sgo1 takes place but is not required for mitotic exit. Finally, we show that Bub1 regulates Sgo1 protein levels through a mechanism that does not involve APC/C-mediated degradation.
###end p 9
###begin title 10
EXPERIMENTAL PROCEDURES
###end title 10
###begin p 11
###xml 0 29 0 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Antibodies and Immunoblotting</italic>
###xml 111 112 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 114 116 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
Antibodies and Immunoblotting-The production of alpha-Sgo1 and alpha-APC2 antibodies was described previously (9, 21). The following antibodies were purchased from commercial sources: CREST (ImmunoVision), alpha-cyclin B1 (Santa Cruz Biotechnology), alpha-HA and alpha-Myc (Roche Applied Science). For immunoblotting, the antibodies were used at 1:2000 dilution for crude sera or 1 mug/ml for purified IgG.
###end p 11
###begin p 12
###xml 0 57 0 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mammalian Cell Culture, Drug Treatments, and Transfection</italic>
###xml 198 201 198 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m l</sc>
###xml 233 234 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 290 291 290 291 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 377 378 377 378 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 504 505 503 504 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 177 183 <span type="species:ncbi:9913">bovine</span>
Mammalian Cell Culture, Drug Treatments, and Transfection-HeLa Tet-On (Clontech) cells were grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum and 10 mm l-glutamine. To arrest cells at G1/S, cells were incubated in growth medium containing 2 mm thymidine (Sigma) for 18 h. To arrest cells in mitosis, cells were treated with 300 nm nocodazole (Sigma) for 16-18 h or as indicated. Cycloheximide was added to the medium when needed at a concentration of 50 mum.
###end p 12
###begin p 13
Plasmid transfection was performed when cells reached 50% confluency using the Effectene reagent (Qiagen) according to the manufacturer's protocols. The plasmids were derived from pCS2-Myc or pCS2-HA. For RNAi experiments, HeLa cells were transfected using Lipofectamine RNAiMax (Invitrogen) according to manufacturer's protocols and analyzed 36-48 h after transfection. For RNAi experiments, the siRNA were chemically synthesized at Dharmacon. The sequences of the siRNAs used in this study are Bub1-targeting siRNA oligonucleotide (GAGUGAUCACGAUUUCUAUTT) and Sgo1 siRNA (GAGGGGACCCUUUUACAGATT).
###end p 13
###begin p 14
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 129 146 129 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;KEN/&#916;DB2</sup>
To establish stable cell lines, HeLa Tet-On cells were transfected with pTRE2-Myc based plasmids encoding Myc-Sgo1WT and Myc-Sgo1DeltaKEN/DeltaDB2, and selection of stable clones was performed in the presence of 300 mug/ml hygromycin. The surviving clones were screened for the induced expression of corresponding Myc-tagged proteins in the absence or presence of 1 mug/ml doxycycline (Clontech).
###end p 14
###begin p 15
###xml 0 51 0 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunofluorescence and Metaphase Chromosome Spreads</italic>
###xml 155 156 155 156 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 335 337 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 589 590 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 739 741 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
Immunofluorescence and Metaphase Chromosome Spreads-Mitotic cells were harvested by shake-off and swelled in a prewarmed hypotonic solution containing 55 mm KCl for 15 min at 37 degreesC. Cells were spun onto microscope slides at 1500 rpm for 4 min using a Shandon Cytospin centrifuge. Chromosomes were fixed and stained as described (12). Images were acquired and processed with the Slidebook software (Intelligent Imaging) and pseudocolored in Photoshop. A series of z-stack images were captured at 0.2-0.3-mum intervals and deconvolved using the nearest neighbor algorithm. The maximum z-projection is then created for the deconvolved images. For the analysis of chromosome morphology, a Giemsa staining protocol was used as described (22).
###end p 15
###begin p 16
###xml 0 46 0 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Vitro Translation and Ubiquitination Assays</italic>
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 268 270 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 311 317 <span type="species:ncbi:9986">rabbit</span>
In Vitro Translation and Ubiquitination Assays-The in vitro transcription and translation system was purchased from Promega, and the reactions were performed according to the manufacturer's instructions. Briefly, 80 ng of plasmid DNA, nuclease-free water, 0.2 mul of [35S]methionine (10 muCi/mul), and 4 mul of rabbit reticulocyte lysate were mixed to give a final volume of 5 mul. The reaction mixture was incubated at 30 degreesC for 90 min.
###end p 16
###begin p 17
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 362 363 360 361 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 379 380 376 377 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 426 427 422 423 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 457 465 452 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 50 57 <span type="species:ncbi:8355">Xenopus</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
The interphase APC/C was purified from interphase Xenopus egg extracts using anti-APC3/Cdc27 antibody coupled to protein A support as described (23, 24). The expression and purification of human Cdc20 and Cdh1 proteins from Sf9 cells were described previously (23, 25). Each ubiquitination assay contained a 5-mul mixture of an energy-regenerating system, 150 mum ubiquitin, 5 mum recombinant ubiquitin-activating enzyme, 2 mum recombinant UbcH10, 1 mul of in vitro transcribed and translated substrates, and 3 mul of the APC/C beads.
###end p 17
###begin p 18
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Live-cell Imaging</italic>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 409 410 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
Live-cell Imaging-For live-cell imaging, eGFP-H2B-expressing cells were plated in 4-well chambered coverslips (LabTek) and synchronized in early S-phase by thymidine arrest for 18 h and released into fresh medium just before filming. Doxycycline was added to induce Sgo1 expression 24 h before filming. Cells were imaged in CO2-independent medium (Invitrogen) at 37 degreesC using a Deltavision microscope. 3 z-stacks were acquired every 2 min for 24 h. Image manipulations were performed in ImageJ (contrast enhancement, cropping, and conversion to Quicktime).
###end p 18
###begin title 19
RESULTS
###end title 19
###begin p 20
###xml 0 73 0 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 Is Degraded during Mitotic Exit, and Its Degradation Depends on Cdh1</italic>
###xml 220 221 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 705 712 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
Sgo1 Is Degraded during Mitotic Exit, and Its Degradation Depends on Cdh1-Previous studies have shown that the protein level of Sgo1 in nocodazole-arrested mitotic cells is higher than that of Sgo1 in cells enriched in G1/S phase by thymidine arrest (9), suggesting that Sgo1 levels are regulated during the cell cycle. To confirm this finding, we examined Sgo1 steady-state levels in synchronized cell cultures. HeLa cells were arrested in mitosis by nocodazole treatment and released into fresh medium. Then cells were harvested at different time points, and Sgo1 proteins levels were analyzed by Western blotting. The Sgo1 protein level was high in mitosis but dropped sharply upon nocodazole release (Fig. 1A). In contrast, the protein level of Apc2 remained unchanged, serving as a loading control. The Sgo1 profile during this experiment was similar to that of cyclin B1. Many proteins, including cyclin B1, undergo rapid degradation during mitotic exit to coordinate exit from mitosis. A sharp decrease in Sgo1 protein level suggests that this protein is degraded during mitotic exit.
###end p 20
###begin p 21
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 134 141 134 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
In addition to the band at about 80 kDa that corresponded to the full-length Sgo1, we observed two additional bands of smaller sizes (Fig. 1A). It is well documented that Sgo1 has several isoforms produced by alternative splicing (11). These two smaller protein bands had sizes corresponding to the proteins produced from two major Sgo1 splice variants, suggesting that they very likely were Sgo1 isoforms (26, 27). Their protein levels were reduced upon release from nocodazole in the same fashion as the full-length Sgo1, suggesting that they too were degraded during mitotic exit.
###end p 21
###begin p 22
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 112 119 112 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 235 239 235 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 437 441 437 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 443 450 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 452 459 452 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 112 119 <span type="species:ncbi:8355">Xenopus</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
Many proteins degraded during mitotic exit, such as cyclin B1, Bub1, or Plk1, are substrates for APC/CCdh1. The Xenopus Sgo1 protein has been shown to be a substrate of APC/C (8). We next tested that human Sgo1 was a substrate of APC/CCdh1. We transfected HeLa cells with Myc-Sgo1 in the absence or presence of HA-Cdh1. Overexpression of Cdh1 greatly reduced the protein levels of Myc-Sgo1, supporting that Sgo1 was a substrate for APC/CCdh1 (Fig. 1B, lanes 1 and 2).
###end p 22
###begin p 23
###xml 339 346 339 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 415 417 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XX</italic>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XXX</italic>
###xml 478 479 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 470 485 470 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>C</italic> and <italic>D</italic></xref>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 537 539 537 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XX</italic>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XXXX</italic>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 865 872 865 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 1041 1048 1041 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1128 1129 1128 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1122 1129 1122 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 329 334 <span type="species:ncbi:10090">mouse</span>
###xml 339 346 <span type="species:ncbi:8355">Xenopus</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 503 510 <span type="species:ncbi:8355">Xenopus</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
###xml 751 756 <span type="species:ncbi:9606">human</span>
###xml 1031 1036 <span type="species:ncbi:10090">mouse</span>
###xml 1041 1048 <span type="species:ncbi:8355">Xenopus</span>
APC substrates generally contain cis-elements, such as D boxes or KEN boxes, required for their ubiquitination. We asked whether the Sgo1 protein also had those elements. We carefully inspected the sequence of Sgo1 and identified a putative KEN box corresponding to residues 310-312 of human Sgo1. This motif is not conserved in mouse and Xenopus Sgo1. We also found two putative D boxes with a consensus motif of RXXLXXXN in human Sgo1 at residues 192-200 and 457-465 (Fig. 1, C and D). Both mouse and Xenopus Sgo1 proteins contain an RXXLXXXXN motif that corresponds to residues 438-446 in human Sgo1, except that human Sgo1 contains a histidine instead of an arginine at position 438. We decided to consider residues 438-446 as a putative D box in human Sgo1. We named it D box 2 (DB2), whereas two others were named D box 1 (DB1) and D box 3 (DB3) accordingly (Fig. 1D). DB2 and DB3 are located next to each other in the C-terminal portion of Sgo1. DB1 is in the middle portion of the protein. DB1 and DB3 are not conserved in mouse and Xenopus Sgo1, whereas DB2 is conserved with the exception of the first arginine (Fig. 1D).
###end p 23
###begin p 24
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 73 9 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The protein levels of Sgo1 decrease rapidly during mitotic exit.</bold>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Noc</italic>
###xml 423 432 423 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asterisks</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 630 631 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 752 753 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 821 828 821 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 9 918 9 918 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><bold>The protein levels of Sgo1 decrease rapidly during mitotic exit.</bold><italic>A</italic>, HeLa cells were arrested in mitosis by nocodazole (<italic>Noc</italic>), released into fresh growth medium, and collected at the indicated time points. The cell lysates were immunoprecipitated with anti-Sgo1, and the anti-Sgo1 immunoprecipitates were blotted with anti-Sgo1. The cell lysates were also blotted with anti-cyclin B1 and anti-Apc2 (loading control). <italic>Asterisks</italic> indicate putative Sgo1 isoforms. <italic>B</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>C</italic>, domain structure of human Sgo1. The putative APC/C degrons, the coiled coil motif, and the basic domain are indicated. <italic>D</italic>, sequence alignment of the C-terminal regions of human, mouse, and <italic>Xenopus</italic> Sgo1 proteins, showing the conservation of the putative D box 2 (DB2) but not DB1 or DB3.</p>
###xml 9 918 9 918 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25"><bold>The protein levels of Sgo1 decrease rapidly during mitotic exit.</bold><italic>A</italic>, HeLa cells were arrested in mitosis by nocodazole (<italic>Noc</italic>), released into fresh growth medium, and collected at the indicated time points. The cell lysates were immunoprecipitated with anti-Sgo1, and the anti-Sgo1 immunoprecipitates were blotted with anti-Sgo1. The cell lysates were also blotted with anti-cyclin B1 and anti-Apc2 (loading control). <italic>Asterisks</italic> indicate putative Sgo1 isoforms. <italic>B</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>C</italic>, domain structure of human Sgo1. The putative APC/C degrons, the coiled coil motif, and the basic domain are indicated. <italic>D</italic>, sequence alignment of the C-terminal regions of human, mouse, and <italic>Xenopus</italic> Sgo1 proteins, showing the conservation of the putative D box 2 (DB2) but not DB1 or DB3.</p></caption>
###xml 918 918 918 918 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960001"/>
###xml 0 918 0 918 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="25"><bold>The protein levels of Sgo1 decrease rapidly during mitotic exit.</bold><italic>A</italic>, HeLa cells were arrested in mitosis by nocodazole (<italic>Noc</italic>), released into fresh growth medium, and collected at the indicated time points. The cell lysates were immunoprecipitated with anti-Sgo1, and the anti-Sgo1 immunoprecipitates were blotted with anti-Sgo1. The cell lysates were also blotted with anti-cyclin B1 and anti-Apc2 (loading control). <italic>Asterisks</italic> indicate putative Sgo1 isoforms. <italic>B</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>C</italic>, domain structure of human Sgo1. The putative APC/C degrons, the coiled coil motif, and the basic domain are indicated. <italic>D</italic>, sequence alignment of the C-terminal regions of human, mouse, and <italic>Xenopus</italic> Sgo1 proteins, showing the conservation of the putative D box 2 (DB2) but not DB1 or DB3.</p></caption><graphic xlink:href="zbc0070963960001"/></fig>
###xml 653 658 <span type="species:ncbi:9606">human</span>
###xml 803 808 <span type="species:ncbi:9606">human</span>
###xml 810 815 <span type="species:ncbi:10090">mouse</span>
###xml 821 828 <span type="species:ncbi:8355">Xenopus</span>
FIGURE 1.The protein levels of Sgo1 decrease rapidly during mitotic exit.A, HeLa cells were arrested in mitosis by nocodazole (Noc), released into fresh growth medium, and collected at the indicated time points. The cell lysates were immunoprecipitated with anti-Sgo1, and the anti-Sgo1 immunoprecipitates were blotted with anti-Sgo1. The cell lysates were also blotted with anti-cyclin B1 and anti-Apc2 (loading control). Asterisks indicate putative Sgo1 isoforms. B, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. C, domain structure of human Sgo1. The putative APC/C degrons, the coiled coil motif, and the basic domain are indicated. D, sequence alignment of the C-terminal regions of human, mouse, and Xenopus Sgo1 proteins, showing the conservation of the putative D box 2 (DB2) but not DB1 or DB3.
###end p 24
###begin p 25
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The protein levels of Sgo1 decrease rapidly during mitotic exit.</bold>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Noc</italic>
###xml 414 423 414 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asterisks</italic>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 743 744 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 812 819 812 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 644 649 <span type="species:ncbi:9606">human</span>
###xml 794 799 <span type="species:ncbi:9606">human</span>
###xml 801 806 <span type="species:ncbi:10090">mouse</span>
###xml 812 819 <span type="species:ncbi:8355">Xenopus</span>
The protein levels of Sgo1 decrease rapidly during mitotic exit.A, HeLa cells were arrested in mitosis by nocodazole (Noc), released into fresh growth medium, and collected at the indicated time points. The cell lysates were immunoprecipitated with anti-Sgo1, and the anti-Sgo1 immunoprecipitates were blotted with anti-Sgo1. The cell lysates were also blotted with anti-cyclin B1 and anti-Apc2 (loading control). Asterisks indicate putative Sgo1 isoforms. B, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. C, domain structure of human Sgo1. The putative APC/C degrons, the coiled coil motif, and the basic domain are indicated. D, sequence alignment of the C-terminal regions of human, mouse, and Xenopus Sgo1 proteins, showing the conservation of the putative D box 2 (DB2) but not DB1 or DB3.
###end p 25
###begin p 26
###xml 588 589 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 582 589 562 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
To determine whether these motifs were important for Sgo1 degradation, we first made mutants with either DB1 or DB3 deleted (DeltaDB1 or DeltaDB3), as they both had a perfect consensus motif. We also made a mutant with the KEN box deleted (DeltaKEN) and a double mutant with both DB3 and the KEN box deleted (DeltaKEN/DeltaDB3). HeLa cells were transfected with these Myc-Sgo1 mutant constructs with or without the HA-Cdh1 expression vector, and the protein levels were examined by Western blotting. The protein levels of all Sgo1 mutants were still reduced by Cdh1 overexpression (Fig. 1B). These data suggest that either those motifs are not functional, or deletion of each motif alone may not be sufficient to stabilize Sgo1. It is also possible that DB2 or other degradation motifs may mediate Sgo1 degradation.
###end p 26
###begin p 27
###xml 0 55 0 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Degradation of Sgo1 Requires Both KEN- and D-box Motifs</italic>
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 253 260 253 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 358 365 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 569 570 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 563 570 563 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 572 579 572 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 584 585 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 820 824 820 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 885 886 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 879 886 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 888 901 888 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3, 4, 9</italic>
###xml 907 909 907 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
Degradation of Sgo1 Requires Both KEN- and D-box Motifs-To systematically identify what regions of Sgo1 were important for its degradation, we made three constructs containing N-terminal (Sgo1N), middle (Sgo1M), or C-terminal (Sgo1C) fragments of Sgo1 (Fig. 2A). Sgo1N does not contain putative degradation motifs. Sgo1M has the putative KEN and DB1 motifs (Fig. 1D). Sgo1C has the putative DB2 and DB3 motifs. These constructs were expressed in HeLa cells in the absence or presence of Cdh1 overexpression. Myc-Sgo1N was stable even with overexpression of Cdh1 (Fig. 2B, lanes 1 and 2), consistent with the lack of putative degradation motifs in this region. By contrast, the protein levels of both Myc-Sgo1M and Myc-Sgo1C were reduced by Cdh1 overexpression, suggesting that both fragments might be substrates of APC/CCdh1 and that Sgo1 might have multiple degradation motifs (Fig. 2B, lanes 3, 4, 9, and 10).
###end p 27
###begin p 28
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 181 190 181 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5-8</italic>
###xml 569 570 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 563 570 563 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 572 579 572 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 584 585 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 712 713 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 706 713 706 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 715 722 715 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 9</italic>
###xml 727 729 727 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 910 911 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 904 911 904 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 913 921 913 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 11</italic>
###xml 926 928 926 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12</italic>
###xml 1235 1247 1235 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;440-444</sup>
###xml 1257 1269 1253 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;445-449</sup>
###xml 1277 1278 1269 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1271 1278 1263 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 1280 1289 1272 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3-6</italic>
###xml 1619 1631 1611 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;455-459</sup>
###xml 1640 1652 1628 1636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;460-464</sup>
###xml 1843 1847 1827 1831 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
To determine which degradation motifs in Sgo1M were functional, we made two Sgo1M constructs lacking either KEN box or DB1 and examined their protein levels in HeLa cells (Fig. 2B, lanes 5-8). Deletion of the KEN box, but not DB1, stabilized Sgo1M in the presence of Cdh1 overexpression. Thus, degradation of Sgo1M depends on the KEN box. The KEN box is a functional APC/C degron capable of driving efficient degradation of Sgo1M. Removal of this motif alone, however, was insufficient to stabilize full-length Sgo1 protein in the presence of overexpressed Cdh1 (Fig. 1B, lanes 3 and 4), suggesting that Sgo1 might have several degradation motifs. Consistently, Sgo1C underwent Cdh1-dependent degradation (Fig. 2B, lanes 9 and 10), suggesting that an additional degradation motif(s) was present in this region. Deletion of the putative DB3 did not stabilize Sgo1C in the presence of Cdh1 overexpression (Fig. 2B, lanes 11 and 12), indicating that this motif was not functional. To determine whether DB2 was critical for the degradation of Sgo1C, we made several constructs of Sgo1C with consecutive deletions of 5 residues in the region containing residues 440-469 in Sgo1. Overexpression of Cdh1 did not reduce protein levels of Sgo1CDelta440-444 and Sgo1CDelta445-449 (Fig. 2C, lanes 3-6). DB2 was partially deleted in both of these mutants, indicating that DB2 was required for Cdh1-dependent degradation of Sgo1C. By contrast, other Sgo1C mutants with residues neighboring DB2 deleted were not stabilized. Consistent with the putative DB3 not being functional, two Sgo1C constructs with DB3 partially deleted, Sgo1CDelta455-459 and Sgo1Delta460-464, were still degraded by Cdh1 overexpression. Thus, degradation of Sgo1 in the presence of an excess amount of Cdh1 depends on both its KEN-box and DB2, suggesting that Sgo1 might be an APC/CCdh1 substrate with multiple degrons.
###end p 28
###begin p 29
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 93 9 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 degradation induced by Cdh1 overexpression depends on both its KEN and D boxes.</bold>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 9 544 9 544 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30"><bold>Sgo1 degradation induced by Cdh1 overexpression depends on both its KEN and D boxes.</bold><italic>A</italic>, schematic diagram of the boundaries of the N-terminal (Sgo1N), middle (Sgo1M), and C-terminal (Sgo1C) fragments of Sgo1. <italic>B</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>C</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies.</p>
###xml 9 544 9 544 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30"><bold>Sgo1 degradation induced by Cdh1 overexpression depends on both its KEN and D boxes.</bold><italic>A</italic>, schematic diagram of the boundaries of the N-terminal (Sgo1N), middle (Sgo1M), and C-terminal (Sgo1C) fragments of Sgo1. <italic>B</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>C</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies.</p></caption>
###xml 544 544 544 544 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960002"/>
###xml 0 544 0 544 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="30"><bold>Sgo1 degradation induced by Cdh1 overexpression depends on both its KEN and D boxes.</bold><italic>A</italic>, schematic diagram of the boundaries of the N-terminal (Sgo1N), middle (Sgo1M), and C-terminal (Sgo1C) fragments of Sgo1. <italic>B</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>C</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies.</p></caption><graphic xlink:href="zbc0070963960002"/></fig>
FIGURE 2.Sgo1 degradation induced by Cdh1 overexpression depends on both its KEN and D boxes.A, schematic diagram of the boundaries of the N-terminal (Sgo1N), middle (Sgo1M), and C-terminal (Sgo1C) fragments of Sgo1. B, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. C, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies.
###end p 29
###begin p 30
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 degradation induced by Cdh1 overexpression depends on both its KEN and D boxes.</bold>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
Sgo1 degradation induced by Cdh1 overexpression depends on both its KEN and D boxes.A, schematic diagram of the boundaries of the N-terminal (Sgo1N), middle (Sgo1M), and C-terminal (Sgo1C) fragments of Sgo1. B, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. C, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies.
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 40 44 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 9 84 9 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ubiquitination of Sgo1 by APC/C<sup>Cdh1</sup><italic>in vitro</italic> depends on its KEN and D boxes.</bold>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 257 265 257 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 297 299 297 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 9 568 9 568 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>Ubiquitination of Sgo1 by APC/C<sup>Cdh1</sup><italic>in vitro</italic> depends on its KEN and D boxes.</bold><italic>A</italic>, APC/C was immunoprecipitated from <italic>Xenopus</italic> egg extracts using anti-APC3/Cdc27 antibody beads and supplemented with recombinant Cdc20 or Cdh1. Sgo1N, Sgo1M, and Sgo1C were <italic>in vitro</italic> translated in the presence of [<sup>35</sup>S]methionine and used as substrates in the ubiquitination reactions. The reaction mixtures were separated by SDS-PAGE and analyzed using phosphorimaging. <italic>B</italic>, same as in <italic>A</italic> except that Sgo1C deletion mutants were used as substrates for ubiquitination with or without Cdh1.</p>
###xml 9 568 9 568 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>Ubiquitination of Sgo1 by APC/C<sup>Cdh1</sup><italic>in vitro</italic> depends on its KEN and D boxes.</bold><italic>A</italic>, APC/C was immunoprecipitated from <italic>Xenopus</italic> egg extracts using anti-APC3/Cdc27 antibody beads and supplemented with recombinant Cdc20 or Cdh1. Sgo1N, Sgo1M, and Sgo1C were <italic>in vitro</italic> translated in the presence of [<sup>35</sup>S]methionine and used as substrates in the ubiquitination reactions. The reaction mixtures were separated by SDS-PAGE and analyzed using phosphorimaging. <italic>B</italic>, same as in <italic>A</italic> except that Sgo1C deletion mutants were used as substrates for ubiquitination with or without Cdh1.</p></caption>
###xml 568 568 568 568 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960003"/>
###xml 0 568 0 568 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="32"><bold>Ubiquitination of Sgo1 by APC/C<sup>Cdh1</sup><italic>in vitro</italic> depends on its KEN and D boxes.</bold><italic>A</italic>, APC/C was immunoprecipitated from <italic>Xenopus</italic> egg extracts using anti-APC3/Cdc27 antibody beads and supplemented with recombinant Cdc20 or Cdh1. Sgo1N, Sgo1M, and Sgo1C were <italic>in vitro</italic> translated in the presence of [<sup>35</sup>S]methionine and used as substrates in the ubiquitination reactions. The reaction mixtures were separated by SDS-PAGE and analyzed using phosphorimaging. <italic>B</italic>, same as in <italic>A</italic> except that Sgo1C deletion mutants were used as substrates for ubiquitination with or without Cdh1.</p></caption><graphic xlink:href="zbc0070963960003"/></fig>
###xml 121 128 <span type="species:ncbi:8355">Xenopus</span>
FIGURE 3.Ubiquitination of Sgo1 by APC/CCdh1in vitro depends on its KEN and D boxes.A, APC/C was immunoprecipitated from Xenopus egg extracts using anti-APC3/Cdc27 antibody beads and supplemented with recombinant Cdc20 or Cdh1. Sgo1N, Sgo1M, and Sgo1C were in vitro translated in the presence of [35S]methionine and used as substrates in the ubiquitination reactions. The reaction mixtures were separated by SDS-PAGE and analyzed using phosphorimaging. B, same as in A except that Sgo1C deletion mutants were used as substrates for ubiquitination with or without Cdh1.
###end p 31
###begin p 32
###xml 31 35 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ubiquitination of Sgo1 by APC/C<sup>Cdh1</sup><italic>in vitro</italic> depends on its KEN and D boxes.</bold>
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 112 119 112 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 248 256 248 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 112 119 <span type="species:ncbi:8355">Xenopus</span>
Ubiquitination of Sgo1 by APC/CCdh1in vitro depends on its KEN and D boxes.A, APC/C was immunoprecipitated from Xenopus egg extracts using anti-APC3/Cdc27 antibody beads and supplemented with recombinant Cdc20 or Cdh1. Sgo1N, Sgo1M, and Sgo1C were in vitro translated in the presence of [35S]methionine and used as substrates in the ubiquitination reactions. The reaction mixtures were separated by SDS-PAGE and analyzed using phosphorimaging. B, same as in A except that Sgo1C deletion mutants were used as substrates for ubiquitination with or without Cdh1.
###end p 32
###begin p 33
###xml 0 39 0 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 Is Ubiquitinated by APC/C In Vitro</italic>
###xml 132 136 132 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 145 150 145 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdc20</sup>
###xml 189 197 189 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 266 274 266 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 295 297 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 394 395 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 388 395 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 397 406 397 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1-3</italic>
###xml 546 550 546 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 567 572 567 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdc20</sup>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 574 581 574 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 583 592 583 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4-9</italic>
###xml 666 667 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 660 667 660 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 669 676 669 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 777 785 777 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;KEN</sup>
###xml 929 930 925 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 923 930 919 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 937 949 933 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;440-444</sup>
###xml 959 971 951 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;445-449</sup>
###xml 1047 1051 1035 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 1059 1060 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1053 1060 1041 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1062 1071 1050 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3-6</italic>
###xml 1170 1171 1158 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1164 1171 1152 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1173 1183 1161 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7-14</italic>
###xml 1240 1244 1228 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 1244 1252 1232 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Sgo1 Is Ubiquitinated by APC/C In Vitro-To confirm that human Sgo1 was a substrate for APC/C, we tested whether immunopurified APC/CCdh1 or APC/CCdc20 could catalyze ubiquitination of Sgo1 in vitro. The three Sgo1 fragments (Sgo1N, Sgo1M, and Sgo1C) were translated in vitro in the presence of [35S]methionine and used as substrates in ubiquitination assays. Sgo1N was not ubiquitinated (Fig. 3A, lanes 1-3), consistent with its inability to undergo Cdh1-mediated degradation in cells. Both Sgo1M and Sgo1C were efficiently ubiquitinated by APC/CCdh1 but not by APC/CCdc20 (Fig. 3A, lanes 4-9). Sgo1M also underwent Cdc20- and Cdh1-independent ubiquitination (Fig. 3A, lanes 4 and 5). The significance of this ubiquitination event was unclear and was not further pursued. Sgo1MDeltaKEN was not ubiquitinated (data not shown), indicating that ubiquitination of this region occurs via the KEN box. Consistent with results in Fig. 2C, Sgo1CDelta440-444 and Sgo1CDelta445-449 that contained deletions of DB2 were not efficiently ubiquitinated by APC/CCdh1 (Fig. 3B, lanes 3-6). Deletions of DB3 and other residues near DB2 did not prevent the ubiquitination of Sgo1C (Fig. 3B, lanes 7-14). Our results indicate that Sgo1 is a substrate of APC/CCdh1in vitro and that it contains two functional APC/C degrons, the KEN box and DB2.
###end p 33
###begin p 34
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 77 9 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 with its KEN and D boxes deleted is stable during mitotic exit.</bold>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 241 242 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 294 296 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 304 321 304 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;KEN/&#916;DB2</sup>
###xml 365 367 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 436 439 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
###xml 499 500 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 518 519 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 553 555 545 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 646 647 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 693 695 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 703 705 695 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 899 900 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 976 978 968 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 990 992 982 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 1075 1079 1067 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1108 1111 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1138 1143 1130 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 9 1144 9 1136 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><bold>Sgo1 with its KEN and D boxes deleted is stable during mitotic exit.</bold><italic>A</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>B</italic>, HeLa Tet-on cells stably transfected with Myc-Sgo1<sup>WT</sup> or Sgo1<sup>&#916;KEN/&#916;DB2</sup> (referred to as non-degradable Sgo1 or Sgo1<sup>ND</sup>) were incubated for 24 h in the presence or absence of doxycycline (<italic>Dox</italic>). Cell lysates were blotted with the indicated antibodies. <italic>C</italic>, cell lysates in <italic>B</italic> and lysates of an additional Sgo1<sup>ND</sup> clone were blotted with anti-Sgo1. A cross-reacting band was used as the loading control. <italic>D</italic>, HeLa cells induced with doxycycline for Sgo1<sup>WT</sup> or Sgo1<sup>ND</sup> expression were treated with nocodazole, released into a fresh medium containing cycloheximide, and collected at different time points. Cell lysates were blotted with the indicated antibodies. <italic>E</italic>, mitotic chromosome spreads of HeLa Tet-on cells stably expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence of doxycycline. 4,6-Diamidino-2-phenylindole staining is shown in <italic>blue</italic>. CREST staining is shown in <italic>red</italic>. Myc staining is shown in <italic>green</italic>.</p>
###xml 9 1144 9 1136 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35"><bold>Sgo1 with its KEN and D boxes deleted is stable during mitotic exit.</bold><italic>A</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>B</italic>, HeLa Tet-on cells stably transfected with Myc-Sgo1<sup>WT</sup> or Sgo1<sup>&#916;KEN/&#916;DB2</sup> (referred to as non-degradable Sgo1 or Sgo1<sup>ND</sup>) were incubated for 24 h in the presence or absence of doxycycline (<italic>Dox</italic>). Cell lysates were blotted with the indicated antibodies. <italic>C</italic>, cell lysates in <italic>B</italic> and lysates of an additional Sgo1<sup>ND</sup> clone were blotted with anti-Sgo1. A cross-reacting band was used as the loading control. <italic>D</italic>, HeLa cells induced with doxycycline for Sgo1<sup>WT</sup> or Sgo1<sup>ND</sup> expression were treated with nocodazole, released into a fresh medium containing cycloheximide, and collected at different time points. Cell lysates were blotted with the indicated antibodies. <italic>E</italic>, mitotic chromosome spreads of HeLa Tet-on cells stably expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence of doxycycline. 4,6-Diamidino-2-phenylindole staining is shown in <italic>blue</italic>. CREST staining is shown in <italic>red</italic>. Myc staining is shown in <italic>green</italic>.</p></caption>
###xml 1144 1144 1136 1136 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960004"/>
###xml 0 1144 0 1136 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="35"><bold>Sgo1 with its KEN and D boxes deleted is stable during mitotic exit.</bold><italic>A</italic>, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. <italic>B</italic>, HeLa Tet-on cells stably transfected with Myc-Sgo1<sup>WT</sup> or Sgo1<sup>&#916;KEN/&#916;DB2</sup> (referred to as non-degradable Sgo1 or Sgo1<sup>ND</sup>) were incubated for 24 h in the presence or absence of doxycycline (<italic>Dox</italic>). Cell lysates were blotted with the indicated antibodies. <italic>C</italic>, cell lysates in <italic>B</italic> and lysates of an additional Sgo1<sup>ND</sup> clone were blotted with anti-Sgo1. A cross-reacting band was used as the loading control. <italic>D</italic>, HeLa cells induced with doxycycline for Sgo1<sup>WT</sup> or Sgo1<sup>ND</sup> expression were treated with nocodazole, released into a fresh medium containing cycloheximide, and collected at different time points. Cell lysates were blotted with the indicated antibodies. <italic>E</italic>, mitotic chromosome spreads of HeLa Tet-on cells stably expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence of doxycycline. 4,6-Diamidino-2-phenylindole staining is shown in <italic>blue</italic>. CREST staining is shown in <italic>red</italic>. Myc staining is shown in <italic>green</italic>.</p></caption><graphic xlink:href="zbc0070963960004"/></fig>
FIGURE 4.Sgo1 with its KEN and D boxes deleted is stable during mitotic exit.A, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. B, HeLa Tet-on cells stably transfected with Myc-Sgo1WT or Sgo1DeltaKEN/DeltaDB2 (referred to as non-degradable Sgo1 or Sgo1ND) were incubated for 24 h in the presence or absence of doxycycline (Dox). Cell lysates were blotted with the indicated antibodies. C, cell lysates in B and lysates of an additional Sgo1ND clone were blotted with anti-Sgo1. A cross-reacting band was used as the loading control. D, HeLa cells induced with doxycycline for Sgo1WT or Sgo1ND expression were treated with nocodazole, released into a fresh medium containing cycloheximide, and collected at different time points. Cell lysates were blotted with the indicated antibodies. E, mitotic chromosome spreads of HeLa Tet-on cells stably expressing Myc-Sgo1WT or Myc-Sgo1ND in the presence of doxycycline. 4,6-Diamidino-2-phenylindole staining is shown in blue. CREST staining is shown in red. Myc staining is shown in green.
###end p 34
###begin p 35
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 with its KEN and D boxes deleted is stable during mitotic exit.</bold>
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 285 287 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 295 312 295 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;KEN/&#916;DB2</sup>
###xml 356 358 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 427 430 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
###xml 490 491 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 509 510 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 544 546 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 637 638 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 684 686 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 694 696 686 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 890 891 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 967 969 959 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 981 983 973 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 1066 1070 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1099 1102 1091 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1129 1134 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
Sgo1 with its KEN and D boxes deleted is stable during mitotic exit.A, HeLa cells were transfected with the indicated Sgo1 plasmids with or without the HA-Cdh1 construct. The cell lysates were blotted with the indicated antibodies. B, HeLa Tet-on cells stably transfected with Myc-Sgo1WT or Sgo1DeltaKEN/DeltaDB2 (referred to as non-degradable Sgo1 or Sgo1ND) were incubated for 24 h in the presence or absence of doxycycline (Dox). Cell lysates were blotted with the indicated antibodies. C, cell lysates in B and lysates of an additional Sgo1ND clone were blotted with anti-Sgo1. A cross-reacting band was used as the loading control. D, HeLa cells induced with doxycycline for Sgo1WT or Sgo1ND expression were treated with nocodazole, released into a fresh medium containing cycloheximide, and collected at different time points. Cell lysates were blotted with the indicated antibodies. E, mitotic chromosome spreads of HeLa Tet-on cells stably expressing Myc-Sgo1WT or Myc-Sgo1ND in the presence of doxycycline. 4,6-Diamidino-2-phenylindole staining is shown in blue. CREST staining is shown in red. Myc staining is shown in green.
###end p 35
###begin p 36
###xml 0 71 0 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 with the KEN Box and DB2 Deleted Is Stabilized during Mitotic Exit</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 330 339 330 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3-6</italic>
###xml 436 437 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 430 437 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 738 740 738 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 839 841 839 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 871 873 871 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 1002 1003 1002 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 996 1003 996 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1075 1077 1075 1077 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 1090 1092 1090 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 1180 1181 1180 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1174 1181 1174 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1228 1230 1228 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 1243 1245 1243 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
Sgo1 with the KEN Box and DB2 Deleted Is Stabilized during Mitotic Exit-We next tested whether deletion of both the KEN box and DB2 stabilized full-length Sgo1 in HeLa cells overexpressing Cdh1. As expected, deletion of either KEN or DB2 alone was not sufficient to stabilize Sgo1 in the presence of Cdh1 overexpression (Fig. 4A, lanes 3-6). Deletion of both motifs, however, greatly stabilized Sgo1 in cells overexpressing Cdh1 (Fig. 4A, lanes 7 and 8). Thus, either the KEN box or DB2 of Sgo1 is sufficient to drive its degradation in cells with elevated levels of Cdh1. Deletion of both motifs is required to stabilize Sgo1 in cells. We will hereafter refer to the Sgo1 mutant with both KEN and DB2 deleted as non-degradable Sgo1 (Sgo1ND). We then established cell lines that stably expressed full-length Myc-tagged wild-type Sgo1 (Sgo1WT) or non-degradable Sgo1 (Sgo1ND) driven by a tetracycline-inducible promoter. We verified that Sgo1 expression was induced by doxycycline in these lines (Fig. 4B). Blotting of the cell lysates with anti-Sgo1 readily detected Myc-Sgo1WT and Myc-Sgo1ND in the presence of doxycycline but failed to detect the endogenous Sgo1 protein (Fig. 4C). Therefore, the expression levels of Myc-Sgo1WT and Myc-Sgo1ND were higher than that of the endogenous Sgo1. The signal for endogenous Sgo1 was below the detectable level under these blotting conditions.
###end p 36
###begin p 37
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 350 357 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 359 371 359 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 395 397 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 627 629 627 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 631 638 631 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 640 652 640 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
Next, we examined the kinetics of degradation of Myc-Sgo1WT and Myc-Sgo1ND in these cells after the release from nocodazole-mediated mitotic arrest by blotting the total cell lysates with anti-Myc. As expected, Myc-Sgo1WT was degraded rapidly during mitotic exit, and its degradation profile was similar to that of cyclin B1 and the endogenous Sgo1 (Fig. 4D, upper panels). By contrast, Myc-Sgo1ND was degraded with a much slower kinetics, indicating that deletion of KEN and DB2 greatly impeded the degradation of Sgo1 during mitotic exit. The kinetics of cyclin B1 degradation, however, was unchanged in cells expressing Sgo1ND (Fig. 4D, lower panels), suggesting that timely Sgo1 degradation was not required for proper mitotic exit.
###end p 37
###begin p 38
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 201 203 201 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 239 246 239 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 259 261 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 351 353 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 411 417 411 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 514 516 514 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 528 530 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 689 690 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 681 696 681 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>A</italic> and <italic>B</italic></xref>
###xml 724 726 724 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 734 735 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 728 735 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>D</italic></xref>
###xml 744 746 744 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 754 755 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 748 755 748 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>F</italic></xref>
###xml 820 822 820 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
To ascertain that Sgo1ND was still functional and that the mutations did not grossly affect the functions of Sgo1, we first examined the kinetochore localization of Sgo1ND. Both Myc-Sgo1WT and Myc-Sgo1ND localized normally to centromeres (Fig. 4E). Thus, Sgo1ND retains the ability to localize to centromeres. We next tested whether expression of Sgo1ND rescued the mitotic arrest phenotype of Sgo1 RNAi cells (Fig. 5). For this purpose, we measured the mitotic indices of Sgo1 RNAi cells transfected with Myc-Sgo1WT or Myc-Sgo1ND using flow cytometry. Mitotic cells had 4N DNA content and positive MPM2 staining. As expected, depletion of Sgo1 by RNAi resulted in mitotic arrest (Fig. 5, A and B). Expression of either Sgo1WT (Fig. 5D) or Sgo1ND (Fig. 5F) rescued this mitotic arrest phenotype, indicating that Myc-Sgo1ND was functional.
###end p 38
###begin p 39
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 0 66 0 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ectopic Expression of Sgo1<sup>ND</sup> Does Not Delay Chromosome Segregation</italic>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 291 293 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 686 688 686 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 783 790 783 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 962 963 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 968 969 968 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 954 969 954 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>B</italic> and <italic>C</italic></xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 666 671 <span type="species:ncbi:9606">human</span>
Ectopic Expression of Sgo1ND Does Not Delay Chromosome Segregation-Because human Sgo1 is known to play a role in the protection of centromeric cohesion during mitosis (8-10), we asked whether Sgo1 degradation is required for proper chromosome segregation. Briefly, HeLa cells expressing Sgo1WT or Sgo1ND were synchronized in mitosis by a single thymidine block followed by a 4-h incubation in nocodazole (Fig. 6A). Mitotic cells were collected by mitotic shake-off and released from the mitotic block. Samples were taken at different times. These samples were fixed with Carnoy's fixative, processed for chromosome spreads, and stained with Giemsa. Cells expressing human Sgo1WT or Sgo1ND had chromosomes normally cohered at their centromeres, similar to their non-induced controls (Fig. 6B). Furthermore, the timing of sister-chromatid separation and chromosome decondensation in the induced cells was indistinguishable from their non-induced controls (Fig. 6, B and C). These data indicate that Sgo1 degradation is not required for proper sister-chromatid separation or chromosome decondensation after release from a mitotic block.
###end p 39
###begin p 40
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 9 86 9 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of Sgo1<sup>ND</sup> rescues the mitotic arrest phenotype of Sgo1 RNAi cells.</bold>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 205 207 205 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 259 261 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 303 305 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">boxed</italic>
###xml 9 498 9 498 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41"><bold>Expression of Sgo1<sup>ND</sup> rescues the mitotic arrest phenotype of Sgo1 RNAi cells.</bold> Log phase HeLa cells (<italic>A</italic>), Sgo1 RNAi cells (<italic>B</italic>), cells transfected with Myc-Sgo1<sup>WT</sup> (<italic>C</italic>), cells transfected with both Sgo1<sup>WT</sup> and Sgo1 siRNA (<italic>D</italic>), cells transfected with Myc-Sgo1<sup>ND</sup> (<italic>E</italic>), and cells transfected with both Sgo1<sup>ND</sup> and Sgo1 siRNA (<italic>F</italic>) were fixed and stained with the MPM2 antibody and propidium iodide and subjected to flow cytometry analysis. The mitotic cells were <italic>boxed</italic>. The mitotic indices are indicated.</p>
###xml 9 498 9 498 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41"><bold>Expression of Sgo1<sup>ND</sup> rescues the mitotic arrest phenotype of Sgo1 RNAi cells.</bold> Log phase HeLa cells (<italic>A</italic>), Sgo1 RNAi cells (<italic>B</italic>), cells transfected with Myc-Sgo1<sup>WT</sup> (<italic>C</italic>), cells transfected with both Sgo1<sup>WT</sup> and Sgo1 siRNA (<italic>D</italic>), cells transfected with Myc-Sgo1<sup>ND</sup> (<italic>E</italic>), and cells transfected with both Sgo1<sup>ND</sup> and Sgo1 siRNA (<italic>F</italic>) were fixed and stained with the MPM2 antibody and propidium iodide and subjected to flow cytometry analysis. The mitotic cells were <italic>boxed</italic>. The mitotic indices are indicated.</p></caption>
###xml 498 498 498 498 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960005"/>
###xml 0 498 0 498 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="41"><bold>Expression of Sgo1<sup>ND</sup> rescues the mitotic arrest phenotype of Sgo1 RNAi cells.</bold> Log phase HeLa cells (<italic>A</italic>), Sgo1 RNAi cells (<italic>B</italic>), cells transfected with Myc-Sgo1<sup>WT</sup> (<italic>C</italic>), cells transfected with both Sgo1<sup>WT</sup> and Sgo1 siRNA (<italic>D</italic>), cells transfected with Myc-Sgo1<sup>ND</sup> (<italic>E</italic>), and cells transfected with both Sgo1<sup>ND</sup> and Sgo1 siRNA (<italic>F</italic>) were fixed and stained with the MPM2 antibody and propidium iodide and subjected to flow cytometry analysis. The mitotic cells were <italic>boxed</italic>. The mitotic indices are indicated.</p></caption><graphic xlink:href="zbc0070963960005"/></fig>
FIGURE 5.Expression of Sgo1ND rescues the mitotic arrest phenotype of Sgo1 RNAi cells. Log phase HeLa cells (A), Sgo1 RNAi cells (B), cells transfected with Myc-Sgo1WT (C), cells transfected with both Sgo1WT and Sgo1 siRNA (D), cells transfected with Myc-Sgo1ND (E), and cells transfected with both Sgo1ND and Sgo1 siRNA (F) were fixed and stained with the MPM2 antibody and propidium iodide and subjected to flow cytometry analysis. The mitotic cells were boxed. The mitotic indices are indicated.
###end p 40
###begin p 41
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of Sgo1<sup>ND</sup> rescues the mitotic arrest phenotype of Sgo1 RNAi cells.</bold>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 156 158 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 294 296 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">boxed</italic>
Expression of Sgo1ND rescues the mitotic arrest phenotype of Sgo1 RNAi cells. Log phase HeLa cells (A), Sgo1 RNAi cells (B), cells transfected with Myc-Sgo1WT (C), cells transfected with both Sgo1WT and Sgo1 siRNA (D), cells transfected with Myc-Sgo1ND (E), and cells transfected with both Sgo1ND and Sgo1 siRNA (F) were fixed and stained with the MPM2 antibody and propidium iodide and subjected to flow cytometry analysis. The mitotic cells were boxed. The mitotic indices are indicated.
###end p 41
###begin p 42
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 48 50 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 9 148 9 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation after the release from nocodazole-mediated mitotic arrest.</bold>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 533 535 533 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 547 549 547 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 699 700 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 768 770 768 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 782 784 782 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 9 933 9 933 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><bold>Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation after the release from nocodazole-mediated mitotic arrest.</bold><italic>A</italic>, schematic diagram of drug treatments for experiments shown in <italic>B</italic> and <italic>C</italic>. <italic>B</italic>, three major categories of chromosome morphology observed in chromosome spreads of HeLa Tet-on cells stably transfected with Myc-Sgo1<sup>ND</sup> in the absence or presence of doxycycline (<italic>Dox</italic>) after the release from nocodazole-mediated mitotic arrest. <italic>C</italic>, kinetics of chromosome segregation in cells expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample. <italic>D</italic>, kinetics of chromosome decondensation in cells expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample.</p>
###xml 9 933 9 933 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43"><bold>Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation after the release from nocodazole-mediated mitotic arrest.</bold><italic>A</italic>, schematic diagram of drug treatments for experiments shown in <italic>B</italic> and <italic>C</italic>. <italic>B</italic>, three major categories of chromosome morphology observed in chromosome spreads of HeLa Tet-on cells stably transfected with Myc-Sgo1<sup>ND</sup> in the absence or presence of doxycycline (<italic>Dox</italic>) after the release from nocodazole-mediated mitotic arrest. <italic>C</italic>, kinetics of chromosome segregation in cells expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample. <italic>D</italic>, kinetics of chromosome decondensation in cells expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample.</p></caption>
###xml 933 933 933 933 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960006"/>
###xml 0 933 0 933 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="43"><bold>Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation after the release from nocodazole-mediated mitotic arrest.</bold><italic>A</italic>, schematic diagram of drug treatments for experiments shown in <italic>B</italic> and <italic>C</italic>. <italic>B</italic>, three major categories of chromosome morphology observed in chromosome spreads of HeLa Tet-on cells stably transfected with Myc-Sgo1<sup>ND</sup> in the absence or presence of doxycycline (<italic>Dox</italic>) after the release from nocodazole-mediated mitotic arrest. <italic>C</italic>, kinetics of chromosome segregation in cells expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample. <italic>D</italic>, kinetics of chromosome decondensation in cells expressing Myc-Sgo1<sup>WT</sup> or Myc-Sgo1<sup>ND</sup> in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample.</p></caption><graphic xlink:href="zbc0070963960006"/></fig>
FIGURE 6.Expression of non-degradable Sgo1 (Sgo1ND) does not delay chromosome segregation after the release from nocodazole-mediated mitotic arrest.A, schematic diagram of drug treatments for experiments shown in B and C. B, three major categories of chromosome morphology observed in chromosome spreads of HeLa Tet-on cells stably transfected with Myc-Sgo1ND in the absence or presence of doxycycline (Dox) after the release from nocodazole-mediated mitotic arrest. C, kinetics of chromosome segregation in cells expressing Myc-Sgo1WT or Myc-Sgo1ND in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample. D, kinetics of chromosome decondensation in cells expressing Myc-Sgo1WT or Myc-Sgo1ND in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample.
###end p 42
###begin p 43
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 0 139 0 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation after the release from nocodazole-mediated mitotic arrest.</bold>
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 348 350 348 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 394 397 394 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 524 526 524 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 538 540 538 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 690 691 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 759 761 759 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 773 775 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
Expression of non-degradable Sgo1 (Sgo1ND) does not delay chromosome segregation after the release from nocodazole-mediated mitotic arrest.A, schematic diagram of drug treatments for experiments shown in B and C. B, three major categories of chromosome morphology observed in chromosome spreads of HeLa Tet-on cells stably transfected with Myc-Sgo1ND in the absence or presence of doxycycline (Dox) after the release from nocodazole-mediated mitotic arrest. C, kinetics of chromosome segregation in cells expressing Myc-Sgo1WT or Myc-Sgo1ND in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample. D, kinetics of chromosome decondensation in cells expressing Myc-Sgo1WT or Myc-Sgo1ND in the presence or absence of doxycycline after the release from nocodazole arrest. A total of 100 chromosome spreads were analyzed for each sample.
###end p 43
###begin p 44
###xml 106 108 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 116 118 116 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 573 580 573 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>B</italic></xref>
To confirm these findings, we examined the chromosome morphology and dynamics in cells overexpressing Sgo1WT or Sgo1ND during unperturbed mitoses. Cells expressing Sgo1WT or Sgo1ND were synchronized in early S phase by a double thymidine block and released into fresh medium (Fig. 7A). Doxycycline was added to both cell lines during the second thymidine block. Samples were taken when cells reached their peak mitotic index and analyzed as described above. Chromosome cohesion and morphology in the induced cultures were indistinguishable from their non-induced controls (Fig. 7B). All phases of mitosis were present at the expected ratios, indicating that the inability to degrade Sgo1 does not induce changes in chromosome morphology or mitotic arrest.
###end p 44
###begin p 45
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 48 50 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 9 117 9 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation during unperturbed mitosis.</bold>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 236 238 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
###xml 9 376 9 376 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46"><bold>Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation during unperturbed mitosis.</bold><italic>A</italic>, schematic diagram of the time course of experiments in <italic>B</italic>. <italic>B</italic>, chromosome spreads of HeLa Tet-on cells expressing Sgo1<sup>ND</sup> with or without doxycycline (<italic>Dox</italic>) made 10 h after the release from the second thymidine block. Major categories of morphology were shown.</p>
###xml 9 376 9 376 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46"><bold>Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation during unperturbed mitosis.</bold><italic>A</italic>, schematic diagram of the time course of experiments in <italic>B</italic>. <italic>B</italic>, chromosome spreads of HeLa Tet-on cells expressing Sgo1<sup>ND</sup> with or without doxycycline (<italic>Dox</italic>) made 10 h after the release from the second thymidine block. Major categories of morphology were shown.</p></caption>
###xml 376 376 376 376 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960007"/>
###xml 0 376 0 376 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="46"><bold>Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation during unperturbed mitosis.</bold><italic>A</italic>, schematic diagram of the time course of experiments in <italic>B</italic>. <italic>B</italic>, chromosome spreads of HeLa Tet-on cells expressing Sgo1<sup>ND</sup> with or without doxycycline (<italic>Dox</italic>) made 10 h after the release from the second thymidine block. Major categories of morphology were shown.</p></caption><graphic xlink:href="zbc0070963960007"/></fig>
FIGURE 7.Expression of non-degradable Sgo1 (Sgo1ND) does not delay chromosome segregation during unperturbed mitosis.A, schematic diagram of the time course of experiments in B. B, chromosome spreads of HeLa Tet-on cells expressing Sgo1ND with or without doxycycline (Dox) made 10 h after the release from the second thymidine block. Major categories of morphology were shown.
###end p 45
###begin p 46
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of non-degradable Sgo1 (Sgo1<sup>ND</sup>) does not delay chromosome segregation during unperturbed mitosis.</bold>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 227 229 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 259 262 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
Expression of non-degradable Sgo1 (Sgo1ND) does not delay chromosome segregation during unperturbed mitosis.A, schematic diagram of the time course of experiments in B. B, chromosome spreads of HeLa Tet-on cells expressing Sgo1ND with or without doxycycline (Dox) made 10 h after the release from the second thymidine block. Major categories of morphology were shown.
###end p 46
###begin p 47
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 86 9 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Live cell time-lapse analysis of cells stably expressing non-degradable Sgo1.</bold>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 138 140 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
###xml 359 391 359 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower right corner of each image</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEBD</italic>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 622 624 622 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 633 635 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 9 674 9 674 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48"><bold>Live cell time-lapse analysis of cells stably expressing non-degradable Sgo1.</bold><italic>A</italic>, cells stably expressing non-degradable Sgo1 (Sgo1<sup>ND</sup>) in the absence or presence of doxycycline (<italic>Dox</italic>) were filmed for 20 h after release from thymidine arrest. Selected frames of cells in interphase and different stages of mitosis are shown. Time (h:min) is shown at the <italic>lower right corner of each image</italic>. Nuclear envelope breakdown (<italic>NEBD</italic>) is defined as time 0. <italic>B</italic>, cumulative frequency of cells undergoing anaphase within the indicated time windows after nuclear envelope breakdown. Anaphase timing in HeLa Tet-on cells expressing Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup> was determined from time-lapse movies.</p>
###xml 9 674 9 674 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48"><bold>Live cell time-lapse analysis of cells stably expressing non-degradable Sgo1.</bold><italic>A</italic>, cells stably expressing non-degradable Sgo1 (Sgo1<sup>ND</sup>) in the absence or presence of doxycycline (<italic>Dox</italic>) were filmed for 20 h after release from thymidine arrest. Selected frames of cells in interphase and different stages of mitosis are shown. Time (h:min) is shown at the <italic>lower right corner of each image</italic>. Nuclear envelope breakdown (<italic>NEBD</italic>) is defined as time 0. <italic>B</italic>, cumulative frequency of cells undergoing anaphase within the indicated time windows after nuclear envelope breakdown. Anaphase timing in HeLa Tet-on cells expressing Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup> was determined from time-lapse movies.</p></caption>
###xml 674 674 674 674 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960008"/>
###xml 0 674 0 674 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="48"><bold>Live cell time-lapse analysis of cells stably expressing non-degradable Sgo1.</bold><italic>A</italic>, cells stably expressing non-degradable Sgo1 (Sgo1<sup>ND</sup>) in the absence or presence of doxycycline (<italic>Dox</italic>) were filmed for 20 h after release from thymidine arrest. Selected frames of cells in interphase and different stages of mitosis are shown. Time (h:min) is shown at the <italic>lower right corner of each image</italic>. Nuclear envelope breakdown (<italic>NEBD</italic>) is defined as time 0. <italic>B</italic>, cumulative frequency of cells undergoing anaphase within the indicated time windows after nuclear envelope breakdown. Anaphase timing in HeLa Tet-on cells expressing Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup> was determined from time-lapse movies.</p></caption><graphic xlink:href="zbc0070963960008"/></fig>
FIGURE 8.Live cell time-lapse analysis of cells stably expressing non-degradable Sgo1.A, cells stably expressing non-degradable Sgo1 (Sgo1ND) in the absence or presence of doxycycline (Dox) were filmed for 20 h after release from thymidine arrest. Selected frames of cells in interphase and different stages of mitosis are shown. Time (h:min) is shown at the lower right corner of each image. Nuclear envelope breakdown (NEBD) is defined as time 0. B, cumulative frequency of cells undergoing anaphase within the indicated time windows after nuclear envelope breakdown. Anaphase timing in HeLa Tet-on cells expressing Sgo1WT and Sgo1ND was determined from time-lapse movies.
###end p 47
###begin p 48
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Live cell time-lapse analysis of cells stably expressing non-degradable Sgo1.</bold>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dox</italic>
###xml 350 382 350 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower right corner of each image</italic>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEBD</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 613 615 613 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 624 626 624 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
Live cell time-lapse analysis of cells stably expressing non-degradable Sgo1.A, cells stably expressing non-degradable Sgo1 (Sgo1ND) in the absence or presence of doxycycline (Dox) were filmed for 20 h after release from thymidine arrest. Selected frames of cells in interphase and different stages of mitosis are shown. Time (h:min) is shown at the lower right corner of each image. Nuclear envelope breakdown (NEBD) is defined as time 0. B, cumulative frequency of cells undergoing anaphase within the indicated time windows after nuclear envelope breakdown. Anaphase timing in HeLa Tet-on cells expressing Sgo1WT and Sgo1ND was determined from time-lapse movies.
###end p 48
###begin p 49
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 272 287 272 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, <italic>A</italic> and <italic>B</italic></xref>
Last, a detailed analysis of chromosome dynamics and anaphase timing was performed in live cells by time-lapse microscopy (Fig. 8A). Both cells expressing Sgo1WT or Sgo1ND condensed their chromosomes, formed a metaphase plate, and underwent anaphase with similar timings (Fig. 8, A and B). Taken together, these results indicate that delayed Sgo1 degradation does not prevent chromosome segregation and that Sgo1 degradation is not required for later mitotic processes, such as chromosome decondensation and cytokinesis.
###end p 49
###begin p 50
###xml 0 84 0 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bub1 Regulates the Steady-state Level of Sgo1 through an APC/C-independent Mechanism</italic>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 309 317 309 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 550 552 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 560 562 560 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 638 640 638 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 761 767 761 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 769 778 769 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4-6</italic>
###xml 833 835 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 864 870 864 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 880 889 880 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1-3</italic>
###xml 895 904 895 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4-6</italic>
###xml 925 927 925 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 1012 1018 1012 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 1020 1031 1020 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 10-12</italic>
###xml 1199 1201 1199 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 1336 1338 1336 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 1378 1384 1378 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 1394 1403 1394 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7-9</italic>
###xml 1409 1420 1409 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 10-12</italic>
Bub1 Regulates the Steady-state Level of Sgo1 through an APC/C-independent Mechanism-It has been shown previously that the protein levels of Sgo1 are reduced in Bub1 RNAi cells (9), indicating that Bub1 is required for the maintenance of the steady-state levels of Sgo1. Bub1 also phosphorylates Sgo1 protein in vitro at several sites, including Ser-436 and Ser-440, which are in and around DB2 (data not shown). We, thus, tested whether Bub1 regulated APC/C-dependent degradation of Sgo1. We depleted Bub1 by RNAi in cells stably expressing Myc-Sgo1WT or Sgo1ND and blotted cell lysates with anti-Myc. As expected, the levels of Myc-Sgo1WT were regulated during the cell cycle and were lower in log phase cells than in thymidine- or nocodazole-arrested cells (Fig. 9, lanes 4-6). Depletion of Bub1 further reduced the levels of Sgo1WT under all three conditions (Fig. 9, compare lanes 1-3 with lanes 4-6). The levels of Sgo1ND in log-phase cells were similar to that in thymidine- or nocodazole-arrested cells (Fig. 9, lanes 10-12), consistent with it not being regulated by APC/C. We expected that, if Bub1 regulated Sgo1 levels through preventing APC/C-dependent ubiquitination of Sgo1, then Sgo1ND should not display a reduction in protein levels in Bub1 RNAi cells. In contrast to our expectations, we found that the levels of Sgo1ND were still reduced in Bub1 RNAi cells (Fig. 9, compare lanes 7-9 with lanes 10-12). Thus, our data confirm that Bub1 regulates Sgo1 protein levels but suggest that it does so through a mechanism independent of APC/C.
###end p 50
###begin title 51
DISCUSSION
###end title 51
###begin p 52
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sgo1 Contains Multiple APC/C Degrons</italic>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 541 548 541 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 582 586 582 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 364 369 <span type="species:ncbi:9606">human</span>
###xml 541 548 <span type="species:ncbi:8355">Xenopus</span>
Sgo1 Contains Multiple APC/C Degrons-Sister-chromatid cohesion is crucial for faithful chromosome segregation in mitosis and meiosis (3). Sgo1 is required for the protection of centromeric cohesion from prophase to the metaphase-to-anaphase transition until all kinetochores are properly captured by the spindle microtubules (7). In this study, we have shown that human Sgo1 is degraded in an APC/C-dependent manner during mitotic exit. Overexpression of Cdh1 causes a significant reduction in Sgo1 protein levels. Consistent with our data, Xenopus Sgo1 is also a substrate of APC/CCdh1 (8). We have further identified two functional APC/C degrons, a KEN box and a D box, in Sgo1. Thus, similar to other APC/C substrates, such as securin (28), Cdc6 (29), and Nek2A (30), Sgo1 contains multiple APC/C degrons, which ensure its robust degradation during mitotic exit.
###end p 52
###begin p 53
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 9.</label>
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 83 85 83 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 9 86 9 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Depletion of Bub1 by RNAi decreases steady-state levels of Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup>.</bold>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Noc</italic>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thy</italic>
###xml 195 197 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 199 209 199 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 226 237 226 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 9 344 9 344 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><bold>Depletion of Bub1 by RNAi decreases steady-state levels of Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup>.</bold> Log phase, nocodazole (<italic>Noc</italic>)-treated, or thymidine (<italic>Thy</italic>)-treated HeLa Tet-on cells stably expressing Myc-Sgo1<sup>WT</sup> (<italic>left panel</italic>) or Myc-Sgo1<sup>ND</sup> (<italic>right panel</italic>) were transfected with Bub1 siRNA for 24 h and analyzed by Western blotting with the indicated antibodies.</p>
###xml 9 344 9 344 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54"><bold>Depletion of Bub1 by RNAi decreases steady-state levels of Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup>.</bold> Log phase, nocodazole (<italic>Noc</italic>)-treated, or thymidine (<italic>Thy</italic>)-treated HeLa Tet-on cells stably expressing Myc-Sgo1<sup>WT</sup> (<italic>left panel</italic>) or Myc-Sgo1<sup>ND</sup> (<italic>right panel</italic>) were transfected with Bub1 siRNA for 24 h and analyzed by Western blotting with the indicated antibodies.</p></caption>
###xml 344 344 344 344 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0070963960009"/>
###xml 0 344 0 344 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig9"><label>FIGURE 9.</label><caption><p textid="54"><bold>Depletion of Bub1 by RNAi decreases steady-state levels of Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup>.</bold> Log phase, nocodazole (<italic>Noc</italic>)-treated, or thymidine (<italic>Thy</italic>)-treated HeLa Tet-on cells stably expressing Myc-Sgo1<sup>WT</sup> (<italic>left panel</italic>) or Myc-Sgo1<sup>ND</sup> (<italic>right panel</italic>) were transfected with Bub1 siRNA for 24 h and analyzed by Western blotting with the indicated antibodies.</p></caption><graphic xlink:href="zbc0070963960009"/></fig>
FIGURE 9.Depletion of Bub1 by RNAi decreases steady-state levels of Sgo1WT and Sgo1ND. Log phase, nocodazole (Noc)-treated, or thymidine (Thy)-treated HeLa Tet-on cells stably expressing Myc-Sgo1WT (left panel) or Myc-Sgo1ND (right panel) were transfected with Bub1 siRNA for 24 h and analyzed by Western blotting with the indicated antibodies.
###end p 53
###begin p 54
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Depletion of Bub1 by RNAi decreases steady-state levels of Sgo1<sup>WT</sup> and Sgo1<sup>ND</sup>.</bold>
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Noc</italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thy</italic>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT</sup>
###xml 190 200 190 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ND</sup>
###xml 217 228 217 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
Depletion of Bub1 by RNAi decreases steady-state levels of Sgo1WT and Sgo1ND. Log phase, nocodazole (Noc)-treated, or thymidine (Thy)-treated HeLa Tet-on cells stably expressing Myc-Sgo1WT (left panel) or Myc-Sgo1ND (right panel) were transfected with Bub1 siRNA for 24 h and analyzed by Western blotting with the indicated antibodies.
###end p 54
###begin p 55
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 428 435 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 523 530 523 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 796 803 796 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 910 918 910 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 955 962 955 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Sgo1 contains three putative D boxes, but only one D box (DB2) is functional. In another study, DB3 of human Sgo1 was identified as a functional APC/C degron (31). Our results directly contradict those data. We have carefully examined the potential role of DB3 in Sgo1 degradation. In our experiments, removal of DB3 alone or together with the KEN box does not stabilize full-length Sgo1 in the presence of Cdh1 overexpression (Fig. 1B). Similar results were obtained when DB3 was deleted in a C-terminal fragment of Sgo1 (Fig. 2B). A systematic deletional analysis of the C-terminal region of Sgo1 further confirms that DB2 is the only functional APC/C degron in this region, and removal of this motif is solely responsible for the stabilization of Sgo1C in the presence of Cdh1 overexpression (Fig. 2C). Finally, Sgo1C mutants with DB3 partially deleted can still be efficiently ubiquitinated by APC/C in an in vitro reconstituted ubiquitination assay (Fig. 3B). Thus, DB3 is not a functional APC/C degron.
###end p 55
###begin p 56
###xml 0 59 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Degradation of Sgo1 Is Not Required for Mitotic Progression</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
Degradation of Sgo1 Is Not Required for Mitotic Progression-APC/C regulates orderly progression through mitosis by targeting key mitotic regulators for ubiquitination and degradation (16). Sgo1 localizes to kinetochores, protects centromeric cohesion during prophase, and prevents premature sister-chromatid separation in mitosis (7). In meiosis I, the shugoshin family of proteins also protects centromeric cohesin from cleavage by separase. We had initially envisioned that degradation of Sgo1 might be required for its inactivation, thus allowing the timely cleavage of centromeric cohesin by separase at the metaphase-to-anaphase transition. However, expression of a non-degradable mutant of Sgo1 in HeLa cells did not cause a delay in chromosome segregation or mitotic exit. We also did not observe changes in chromosome morphology at different stages of mitosis. These results suggest that degradation of Sgo1 itself is not crucial for proper progression through mitosis. Additional mechanisms may exist to inactivate Sgo1 at the metaphase-to-anaphase transition. Alternatively, Sgo1 does not prevent the cleavage of centromeric cohesin by separase in mitosis.
###end p 56
###begin p 57
###xml 0 68 0 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bub1 Regulates Sgo1 Protein Levels in an APC/C-independent Mechanism</italic>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 226 234 226 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1257 1263 1257 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
Bub1 Regulates Sgo1 Protein Levels in an APC/C-independent Mechanism-The spindle checkpoint kinase Bub1 is required for the maintenance of Sgo1 protein levels (9). Bub1 phosphorylates Sgo1 in the vicinity of its APC/C degrons in vitro. Recently, it has been shown that cyclin-dependent kinases phosphorylate Cdc6 in the vicinity of its APC/C degrons, thus rendering these motifs inaccessible for APC/C recognition and ubiquitination (29). We had hypothesized that Bub1 might regulate Sgo1 through a similar mechanism. This does not appear to be the case, as the levels of the non-degradable Sgo1 mutant are still reduced in Bub1 RNAi cells. Our results, thus, suggest that Bub1 regulates Sgo1 levels through an APC/C-independent mechanism. The centromeric localization of Sgo1 depends on Bub1 (9, 10). It is possible that Sgo1 becomes unstable in Bub1-depleted cells because it loses its centromeric localization. On the other hand, Bub1 targets PP2A to centromeres, which in turn maintains Sgo1 at centromeres by counteracting Plk1-mediated chromosome removal of Sgo1 (12). Although Sgo1 also loses its centromeric localization in PP2A RNAi cells, its protein levels are not reduced in these cells (12). Therefore, the loss of its centromeric localization per se does not necessarily lead to Sgo1 degradation. Future experiments are needed to uncover the mechanisms by which Bub1 regulates the steady-state levels of Sgo1.
###end p 57
###begin p 58
We thank the members of the Yu laboratory for helpful discussions.
###end p 58
###begin p 59
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cdh1</sup>
The abbreviations used are: APC/C, anaphase-promoting complex/cyclosome; APC/CCdh1, the complex between APC/C and Cdh1; D box, destruction box; KEN box, lysine-glutamate-asparagine box; RNAi, RNA interference; HA, hemagglutinin.
###end p 59

